• 제목/요약/키워드: dose appropriateness

검색결과 20건 처리시간 0.024초

국내 3차 병원의 비만 암환자에서 각각 다른 체중 측정 공식들을 적용한 piperacillin/tazobactam의 용량 적절성 비교 연구 (Comparison of Appropriate Piperacillin/Tazobactam Doses in Korean Obese Patients with Cancer Based on Different Body Size Descriptor Equations in a Tertiary Care Hospital)

  • 김지현;양영모;윤현옥;최은주
    • 한국임상약학회지
    • /
    • 제27권2호
    • /
    • pp.83-91
    • /
    • 2017
  • Background: Piperacillin/tazobactam (TZP) is an antibiotic against a broad spectrum of gram-positive, gram-negative, and aerobic and anaerobic strains of bacteria. Due to changes in its pharmacokinetic and pharmacodynamic parameters by TZP-treated patients' renal functions and obesity, it is important to administrate and monitor TZP based on their renal functions and Body Mass Index (BMI) levels. The purpose of this study was to determine the appropriateness of administration doses of TZP based on renal functions of obese cancer patients in a tertiary hospital. Methods: This study was retrospectively conducted with obese cancer patients with $BMI{\geq}30kg/m^2$ in a tertiary hospital, Korea from September 2004 to August 2014. Data were collected through Electronic Medical Record (EMR) which contained laboratory data and TZP dosing of each patient. Results: Among 7,058 patients during the study period, 102 prescriptions were selected based on inclusion and exclusion criteria and classified by their renal functions. Although TZP should be used based on patients' renal functions to adjust its dose, its initial dose and dosing interval were consistently used without considering patients' renal functions on a regular basis. Especially, in the comparison with FDA dosing standard of TZP, approximately twice patients with $20mL/min{\leq}CrCl{\leq}40mL/min$ received domestically 4.5 g instead of 2.25 g as the TZP starting dose. Conclusion: The appropriate doses of TZP were administered to almost all of obese cancer patients; however, the recommended TZP dose was different between Korea and other countries by twice the amount. Further related studies are necessary to clearly determine the results, to optimize TZP treatment for obese patients with cancer in clinical practice, and to design and develop new TZP formulations for them in pharmaceutical industry.

A retrospective analysis of the follicle-stimulating hormone starting dose in expected normal responders undergoing their first in vitro fertilization cycle: proposed dose versus empiric dose

  • Lee, Dayong;Han, Soo Jin;Kim, Seul Ki;Jee, Byung Chul
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제45권4호
    • /
    • pp.183-188
    • /
    • 2018
  • Objective: The purpose of this retrospective study was to evaluate the appropriateness of various follicle-stimulating hormone (FSH) starting doses in expected normal responders based on the nomogram developed by La Marca et al. Methods: A total of 117 first in vitro fertilization cycles performed from 2011 to 2017 were selected. All women were expected normal responders and used a recombinant FSH and flexible gonadotropin-releasing hormone antagonist protocol. The FSH starting dose was empirically determined (150, 225, or 300 IU). The FSH starting dose indicated by La Marca's nomogram was determined using female age and serum $anti-M{\ddot{u}}llerian$ hormone or basal FSH levels. If the administered dose was exactly the same as the proposed dose, the cycle was assigned to the concordant group (34 cycles). If not, it was assigned to the discordant group (83 cycles). Optimal ovarian response was defined as a total of 8-14 oocytes, hypo-response as < 8 oocytes, and hyper-response as > 14 oocytes. Results: Between the concordant and discordant group, ovarian response (optimal, 32.4% vs. 27.7%; hypo-response, 55.9% vs. 54.2%; and hyper-response, 11.8% vs. 18.1%) and the number of total or mature oocytes were similar. Ovarian hyperstimulation syndrome was rare in both groups (0% vs. 1.2%). The implantation rate, clinical pregnancy rate, miscarriage rate, and live birth rate were all similar. Conclusion: The use of the proposed FSH starting dose determined using La Marca's nomogram did not enhance the optimal ovarian response rate or pregnancy rate in expected normal responders. Individualization of the FSH starting dose by La Marca's nomogram appears to have no distinct advantages over empiric choice of the dose in expected normal responders.

Image quality-based dose optimization in pediatric cone-beam computed tomography: A pilot methodological study

  • Hak-Sun Kim;Yoon Joo Choi;Kug Jin Jeon;Sang-Sun Han;Chena Lee
    • Imaging Science in Dentistry
    • /
    • 제54권3호
    • /
    • pp.264-270
    • /
    • 2024
  • Purpose: This study aimed to propose a methodological approach for reducing the radiation dose in pediatric cone-beam computed tomography (CBCT), focusing exclusively on balancing image quality with dose optimization. Materials and Methods: The dose-area product (DAP) for exposure was reduced using copper-plate attenuation of an X-ray source. The thickness of copper (Cu) was increased from 0 to 2.2 mm, and 10 different DAP levels were used. The QUART DVT_AP phantom and pediatric radiologic dentiform were scanned under the respective DAP levels. The contrast-to-noise ratio (CNR), image homogeneity, and modulation transfer function (MTF) were analyzed using the QUART DVT_AP phantom. An expert evaluation (overall image grade, appropriateness of field of view, artifacts, noise, and resolution) was conducted using pediatric dentiform images. The critical DAP level was determined based on phantom and dentiform analysis results. Results: CNR and image homogeneity decreased as the DAP was reduced; however, there was an inflection point of image homogeneity at Cu 1.6 mm (DAP=138.00 mGy·cm2), where the value started increasing. The MTF showed constant values as the DAP decreased. The expert evaluation of overall image grades showed "no diagnostic value" for dentiform images with Cu 1.9-2.2 mm (DAP=78.00-103.33 mGy·cm2). The images with Cu 0-1.6 mm (DAP=138.00-1697.67mGy·cm2) had a "good," "moderate," or "poor but interpretable" grade. Conclusion: Reducing DAP beyond a 1.6-mm Cu thickness degraded CBCT image quality. Image homogeneity and clinical image grades indicated crucial decision points for DAP reduction in pediatric CBCT scans.

수정 델파이 기법을 이용한 의약품의 DDD(일일상용량) 결정과 항생제 사용량 분석: WHO 일일상용량이 없는 항생제를 중심으로 (Determination of Defined Daily Dose of Medicines using Nominal Group Technique and Analysis of Antibiotics Use in National Insurance Claim Data: Focused on Antibiotics without DDD of WHO)

  • 김동숙;김남순;이숙향
    • 한국임상약학회지
    • /
    • 제17권1호
    • /
    • pp.19-32
    • /
    • 2007
  • Objectives : It is necessary to monitor consumption of drugs in order to enhance promote appropriate use of drugs. Defined Daily Dose(DDD) of World Health Organization(WHO) has been used for evaluating the amount of medicine use. However, DDD of some drugs must be determined for drugs in Korea which are not listed by WHO. Our formulary follows ourself classification and DDD of some drugs must be determined since they exist only in Korea. This study was aimed to determine DDD value using RAND Appropriateness Methods and evaluate the amount of antibiotics use using DDD value. Methods : J01 antibiotics of WHO anatomical therapeutic chemical(ATC) classification were extracted from drug formulary. Antibiotics list without DDD was identified to determine their DDD with comprehensive review of references and recommendation of experts. defined. Review of reference was executed. of Expert panels were comprised of clinical pharmacist and clinical doctors. Modified Delphi Method was applied by survey and consensus meeting. Amount of antibiotic use was calculated by DDD/1000 inhabitants/day in the national level using health insurance claim data. Results : The result of 1 round, DDD values of 28 ingredients were determined from the first round of consensus meeting. With 2nd round meeting, 3 ingredients were deleted and DDD of 17 ingredients were decided. Analysis of antibiotic use in health insurance claim data showed 22.97 DDD/1000 inhabitants/day in 2003 year. Conclusion : This study can contribute to the establishment of DDD assignment and thus quantifying drug uses.

  • PDF

정상 성인의 좌심실 벽두께와 내강 크기에 대한 심초음파영상과 전산화단층영상의 비교 (Comparison of Echocardiography and Computed Tomography on Cardiac Wall Thickness and Internal Dimension Size of Left Ventricle in Normal Adults)

  • 지명훈;김성환;성열훈
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제41권6호
    • /
    • pp.545-552
    • /
    • 2018
  • The purpose of this study was evaluated the relationship between echocardiography and cardiac computed tomography in normal adults by visual assessment, and evaluated the effective doses of cardiac computed tomography. The subjects were 100 normal patients who visited two general hospitals in Chungnam, from January 1 to May 30, 2018. We obtained images by using these modalities and evaluated the wall thickness and internal dimension of the Left Ventricle with visual assessment. To evaluate the appropriateness of the visual evaluation, two evaluators who were trained for one week were measured and the agreement between the evaluators were verified by statistical analysis. The effective doses of computed tomography were evaluated using the dose length product. As a result, there was a high correlation between the two modalities. The agreement between the two visual evaluator were also highly agreed. The mean X-ray dose of the subjects was $11.1{\pm}3.1mSv$. Although the purpose of imaging is somewhat different in the clinical setting, echocardiography could achieve the same results as radiation-invasive computed tomography. It is thought that utilization will become even larger.

아크치료기법과 토모테라피치료의 선량분포 비교 (Dose Distribution Comparison between Arc Radiation Therapy and Tomotherapy)

  • 김지윤;이승철;천금성;김영재
    • 한국방사선학회논문지
    • /
    • 제15권5호
    • /
    • pp.723-730
    • /
    • 2021
  • 방사선 치료 시 주로 쓰이는 Arc 치료기법과 Tomotherapy 치료법의 선량적인 측면에서 상호 비교하고자 한다. 대상자는 폐암의 환자를 대상으로 하여 치료계획용적에 60.0 Gy를 처방선량을 기준으로 설정하였다. PTVmean는 Arc의 경우 61.04 Gy, Tomotherapy가 58.50 Gy, 이었다. 전체 폐용적(total lung)은 각각 3.0 Gy, 4.24 Gy, 심장(heart)은 0.13, 0.34, 기도(trachea)는 1.35, 2.58, 식도(Esophagus)는 0.41, 0.86, 척수는 3.65, 4.68의 평균선량을 보였다. DHV 곡선상 치료효과의 적합성은 모두 적합해 보였으며 둘 중에는 Tomotherpy의 치료법이 정상조직 방호적인 측면에서 우세한 것으로 나타났다. 제한적인 공간에서 오랜시간 치료를 받아야 하는 점을 극복한다면 tomotherapy치료가 우세하지만 그렇지 않은 경우 Arc 치료로 진행해도 무방할 것으로 사료된다. 본 연구는 치료계획 영상으로 분석한 것으로 실제 치료의 결과와 다르다는 제한점이 있다. 이러한 제한점을 극복하고자 더 많은 연구를 진행한다면 방사선 치료의 효과는 더욱 상승할 것으로 사료된다.

치과 콘빔 전산화단층검사 시 보루스 차폐체를 이용한 갑상선의 방사선 차폐효과 (Radiation Protective Effect of the Thyroid Gland Using Bolus Protector in the Dental Cone Beam Computed Tomography)

  • 이태희;정승훈;김동우;박명환;김태형
    • 한국방사선학회논문지
    • /
    • 제13권3호
    • /
    • pp.459-464
    • /
    • 2019
  • 치과 콘빔 전산화단층 검사 시 갑상선 부위의 방사선 피폭선량을 최소화하기 위하여 보루스 (Bolus)를 이용한 차폐체를 제작하고, 방사선 차폐 효과와 영상의 적정성을 평가하였다. 치과용 콘빔 전산화단층검사장비를 사용하여 치과방사선 두부 팬텀을 대상으로 갑상선의 좌, 우측 부위에 유리선량계를 부착시켜 방사선량을 측정하였다. 차폐체의 두께를 각각 10 mm, 20 mm, 30 mm로 다르게 하여 각 차폐체별로 흡수선량을 측정하여 차폐체를 사용하지 않았을 경우와 비교하였다. 8명의 평가자가 진료영상의 적정성을 여부를 평가하였다. 왼쪽 갑상선 부위에 30 mm Bolus 차폐체를 사용한 경우에는 결과값이 평균 $342.67{\mu}Gy$로 Bolus 차폐체를 사용하지 않고 측정한 결과값의 평균 $431.22{\mu}Gy$보다 20.7% 감소하였고, 오른쪽 갑상선 부위에 30 mm Bolus 차폐체를 사용한 경우에는 평균 $424.56{\mu}Gy$로 21.9%의 선량감소효과를 보였다. 진료 영상의 적정성은 평가자 모두 사용 가능하다 판단하였다. 결론적으로, 치과 콘빔 전산화단층검사 시 갑상선 부위의 방사선 피폭선량을 최소화하기 위해 제작된 Bolus 차폐체는 장해음영 없이 적정한 진단 영상 처리가 가능하고, 방사선차폐 효과가 있어 유용한 차폐체로 적용 가능할 것으로 사료된다.

반코마이신의 임상약동학 모니터링 서비스에 대한 임상적 및 경제적 손익의 평가 (Clinical and Economic Benefit Evaluation of Therapeutic Drug Monitoring Service on Vancomycin)

  • 배성미;안혜림;홍경자;나현오;조혜경
    • 한국임상약학회지
    • /
    • 제11권1호
    • /
    • pp.1-6
    • /
    • 2001
  • This research is conducted to evaluate the clinical and economic benefits from therapeutic drug monitoring(TDM) service on vancomycin in a tertiary general hospital. Total 99 pairs of steady state peak and trough concentrations of vancomycin were obtained from 73 patients. To see the clinical benefits, the appropriateness of vancomycin dosing before TDM was evaluated. In 72 pairs of vancomycin blood concentrations obtained prior to TDM consultation, $47.2\%$ of the cases had reached within therapeutic range. Serum vancomycin levels in patients with $40{\leq}CLcr<60$ (ml/min) were higher and than the levels in patients with 40>CLcr and $60{\leq}CLcr$ (ml/min). Dose reduction rate in patients with creatinine clearance $40{\leq}CLcr<60$ (ml/min) were also significantly higher than those of compared groups ($61.5\%$, p=0.0138). Serum vancomycin concentrations were re-obtained from 21 patients who received modified dose through TDM service. Ninety percent (19/21cases) of them were within the target therapeutic range. For the evaluation of economic benefits from TDM consultation, estimated cost savings were calculated in those patients. The total drug saving were 586 vials in 21 patients. The calculated mean cost saving from the drugs was 314,570 won (range: $11,273\sim473,466)$ per patient. The study revealed that TDM service for vancomycin is necessary because empirical dosing is not effective for obtaining therapeutic drug level, especially patients with mild renal insufficiencies. The cost saving from TDM is also beneficial for the patients.

  • PDF

방사선 치료용 영상 장치 지침서 작성을 위한 실용적인 고려사항 (Practical Considerations in Preparing an Institutional Procedure of Image Guided Radiation Therapy)

  • 이병용
    • 한국의학물리학회지:의학물리
    • /
    • 제24권4호
    • /
    • pp.205-212
    • /
    • 2013
  • Cone Beam CT (CBCT)와 On Board Imaging (OBI)를 비롯하여 최근에 개발되고 있는 방사선 치료용 영상 장치(Image Guided Radiation Therapy, IGRT)의 사용으로 방사선 치료가 더욱 정확해지고 있다. 점차 사용 범위가 넓어지면서 표준치료법으로 자리잡았고 앞으로 사용하는 기관과 빈도가 더 늘어날 것으로 전망한다. IGRT는 그러나 안전하고 용도에 맞게 사용할 때만 효능을 볼 수 있다. 이를 위해 IGRT를 임상에 적용하기 전에 장치의 특성을 이해하고 병원의 임상 요구에 적합한 지침서를 미리 만들 필요가 있다. QA 프로그램과 환자가 받을 추가 선량에 대한 고려도 미리 준비해둘 필요가 있다.

Preparation and Consideration of Sample Collection in Undeclared Areas for Denuclearization Verification

  • Kim, Dong Yeong;Kim, Giyoon;Lee, Jun;Lim, Kyung Taek;Chung, Heejun;Seo, Jihye;Kim, Myungsoo
    • 방사성폐기물학회지
    • /
    • 제19권4호
    • /
    • pp.479-489
    • /
    • 2021
  • The Republic of Korea is expected to participate in the denuclearization verification activities by the International Atomic Energy Agency (IAEA) in case any neighboring countries declared denuclearization. In this study, samples for the verification of nuclear activities in undeclared areas were selected for the denuclearization of neighboring countries, and the appropriateness of the procedures was considered. If a country with nuclear weapons declares denuclearization, it must be accompanied by the IAEA's verification regarding nuclear materials and weapons in the declared and undeclared areas. The analysis of the process samples or on-site environmental samples and the verification of undeclared nuclear facilities and materials aid in uncovering any evidence of concealment of nuclear activity in undeclared areas. Therefore, a methodology was established for effective sampling and analysis in accordance with proper procedures. Preparations for sampling in undeclared areas were undertaken for various potential scenarios, such as, the establishment of zones according to radiation dose, methods of supplying electricity, wireless communication networks, targets of sampling according to characteristics of nuclides, manned sampling method, and unmanned sampling method. Through this, procedures were established for pre- and post-site settings in preparation for hazards and limiting factors at nuclear inspection sites.